Tumor necrosis factor (TNF) and TNF receptor-associated factor 2 (TRAF2) synergistically function with focal adhesion (FA) signaling, and TRAF2 upregulation in BC [142], promoting cellular resistance to anoikis [143]. The gene discussed is TRAF2; the disease is breast cancer.